Table 1 The clinical characteristics of patients

Number of patients

23

22

22

20

Recipient age (years)

54 ± 19

49 ± 12

58 ± 9

51 ± 21

Male/female

13/10

10/12

13/9

10/10

Time to onset (days)

253 ± 39

192 ± 51

/

/

BMI

22 ± 2.1

19 ± 3.4

20 ± 2.8

23 ± 3.2

AST (U/L)

56 ± 4

61 ± 2

45 ± 4

52 ± 3

ALT (U/L)

35 ± 2

28 ± 1

31 ± 3

31 ± 2

Total bilirubin (mg/dL)

0.95 ± 0.11

0.95 ± 0.16

0.95 ± 0.23

0.95 ± 0.37

Direct bilirubin (mg/dL)

0.45 ± 0.09

0.35 ± 0.14

0.47 ± 0.15

0.30 ± 0.17

Leukocytes (mil/mm³)

9.6 ± 2.1

4.8 ± 1.7

3.6 ± 0.4

4.5 ± 1.1

Haemoglobin (g/dL)

12 ± 2

11 ± 3

10 ± 2

14 ± 2